Mepenzolate Bromide - CAS 76-90-4
Catalog number: 76-90-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C21H26BrNO3
Molecular Weight:
420.34
COA:
Inquire
Targets:
mAChR
Description:
Mepenzolate Bromide is a muscarinic antagonist used to treat gastrointestinal disorders, and decreases the severity of elastase-induced airspace enlargement and respiratory dysfunction.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Cantil
MSDS:
Inquire
1.Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease.
Tanaka K1, Kurotsu S1, Asano T1, Yamakawa N1, Kobayashi D1, Yamashita Y1, Yamazaki H1, Ishihara T1, Watanabe H2, Maruyama T2, Suzuki H3, Mizushima T1. Sci Rep. 2014 Mar 28;4:4510. doi: 10.1038/srep04510.
We recently proposed that mepenzolate bromide (mepenzolate) would be therapeutically effective against chronic obstructive pulmonary disease (COPD) due to its both anti-inflammatory and bronchodilatory activities. In this study, we examined the benefits and adverse effects associated with different routes of mepenzolate administration in mice. Oral administration of mepenzolate caused not only bronchodilation but also decreased the severity of elastase-induced pulmonary emphysema; however, compared with the intratracheal route of administration, about 5000 times higher dose was required to achieve this effect. Intravenously or intrarectally administered mepenzolate also showed these pharmacological effects. The intratracheal route of mepenzolate administration, but not other routes, resulted in protective effects against elastase-induced pulmonary damage and bronchodilation at a much lower dose than that which affected defecation and heart rate.
2.Muscarinic cholinergic receptors in human narcolepsy: a PET study.
Sudo Y1, Suhara T, Honda Y, Nakajima T, Okubo Y, Suzuki K, Nakashima Y, Yoshikawa K, Okauchi T, Sasaki Y, Matsushita M. Neurology. 1998 Nov;51(5):1297-302.
OBJECTIVES: To investigate the function of the muscarinic cholinergic receptor (mAchR) in narcolepsy and the effects of pharmacotherapy on mAchRs.
3.Quantitative capillary column gas chromatographic method for the determination of glycopyrronium in human plasma.
Murray GR, Calvey TN, Williams NE, Chan K. J Chromatogr. 1984 Jun 8;308:143-51.
A new sensitive and selective capillary column gas chromatographic method for the anti-cholinergic agent glycopyrronium bromide in human plasma is described. The procedure involves preliminary ion-pair extraction of the drug into dichloromethane, followed by concentration and analysis of the ion-pair complex by capillary column gas chromatography using a nitrogen-sensitive detector. The method depends on the thermal dequaternisation of the quaternary ammonium compound and can be used to detect 5 ng/ml in a 3-ml plasma sample. The assay procedure has been applied to the determination of the plasma concentration of glycopyrronium after intravenous administration to an anaesthetised patient.
4.Isolation of cholinergic active ingredients in aqueous extracts of Mareya micrantha using the longitudinal muscle of isolated guinea-pig ileum as a pharmacological activity marker.
Tsai CS1, Guede-Guina F, Smith MO, Vangah-Manda M, Ochillo RF. J Ethnopharmacol. 1995 Mar;45(3):215-22.
In our attempt to isolate the pharmacologically active ingredients in the aqueous extracts of Mareya micrantha, we have selected the contractions of the longitudinal muscle of the isolated guinea-pig ileum preparation as a pharmacological marker to monitor retention of pharmacological activity during the chromatographic separation. The aqueous extracts of Mareya micrantha elicited concentration-dependent contractions of the preparation. The maximum response elicited by the aqueous extracts was 50% of the maximum response elicited by the maximum dose of acetylcholine (ACh), 10(-7) M. Mepenzolate (10(-8)-10(-5) M), a specific muscarinic receptor antagonist, similarly antagonized contractions elicited by the aqueous extracts suggesting that the cholinergic ingredient(s) in the extract are acting at the muscarinic receptors of the preparation. Fraction 2-4, which was separated from the aqueous extracts by Sephadex gel chromatography, dose-dependently elicited contractions of the preparation.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mAChR Products


CAS 139886-04-7 Milameline hydrochloride

Milameline hydrochloride
(CAS: 139886-04-7)

Milameline is a non-selective muscarinic acetylcholine receptor partial agonist at all receptor subtypes (Ki values are 2.3, 2.4, 3.6, 3.8 and 4.3 μM for hM1, h...

CAS 2092923-21-0 VU 6008667

VU 6008667
(CAS: 2092923-21-0)

VU 6008667 is a selective negative allosteric modulator (NAM) of M5 muscarinic acetylcholine receptor (mAChR) (IC50 values of 1.2 and 1.6 μM in human and rat M5...

CAS 96487-37-5 Nuvenzepine

Nuvenzepine
(CAS: 96487-37-5)

Nuvenzepine, a new pirenzepine-analog, is an mAChR antagonist, administered intraduodenally, displayed a long-lasting and dose-dependent inhibition of neostigmi...

MK-0969
(CAS: 203321-88-4)

MK-0969 is an Muscarinic M3 antagonist which has the potential for the treatment of chronic obstructive pulmonary diseases.

CAS 84504-69-8 Irsogladine maleate

Irsogladine maleate
(CAS: 84504-69-8)

Irsogladine is a PDE4 inhibitor and muscarinic acetylcholine receptor binder. It inhibits bFGF-induced angiogenesis in wild-type, tPA-knockout, and uPA-knockout...

CAS 52-49-3 Benzhexol HCl

Benzhexol HCl
(CAS: 52-49-3)

Benzhexol HCl is an anticholinergic tertiary amine used to treat parkinsonism and the extrapyramidal side effects of anti-psychotic drugs.

CAS 171722-81-9 YM-46303

YM-46303
(CAS: 171722-81-9)

YM-46303 is an mAChR antagonist which had a binding affinity of 0.39 nM to M3-receptors. YM-46303 exhibits the highest affinities for M1 and M3 receptors. YM-46...

CAS 514-65-8 Biperiden

Biperiden
(CAS: 514-65-8)

Biperiden is an antiparkinsonian agent, which is the selective central M1 cholinoreceptors blocker. It is used for the adjunctive treatment of all forms of Park...

ABET
(CAS: 119630-77-2)

Arecaidine But-2-ynyl Ester Tosylate (ABET) is a potent and selective agonist of M2 recceptors in the atrium versus those in the ileum.

BQCA
(CAS: 338747-41-4)

BQCA is a highly selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor (mAChR), as it dose-dependently reduces the concentration o...

CAS 1227923-29-6 MK-7622

MK-7622
(CAS: 1227923-29-6)

MK-7622 is a cholinesterase inhibitor under evaluation for the treatment of Alzheimer's disease. No studies have been published on this compound in the peer-rev...

CAS 139404-48-1 Tiotropium Bromide hydrate

Tiotropium Bromide hydrate
(CAS: 139404-48-1)

Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a mus...

Desfesoterodine fumarate
(CAS: 380636-50-0)

Desfesoterodine is the active metabolite of fesoterodine as its isobutyrate ester.

CAS 57381-26-7 Irsogladine

Irsogladine
(CAS: 57381-26-7)

Irsogladine is a PDE4 inhibitor and muscarinic acetylcholine receptor binder.Irsogladine treatment (300 and 500 mg/kg/day) resulted in a dose-dependent reductio...

CAS 62-97-5 Diphemanil Methylsulfate

Diphemanil Methylsulfate
(CAS: 62-97-5)

Diphemanil Methylsulfate is a quaternary ammonium anticholinergic.It binds muscarinic acetycholine receptors (mAchR).

CAS 22254-24-6 Ipratropium bromide

Ipratropium bromide
(CAS: 22254-24-6)

Ipratropium bromide, under the trade name Atrovent, structurally similar to atropine, is a muscarinic antagonist and a bronchodilator.

CAS 153504-70-2 Cevimeline hydrochloride hemihydrate

Cevimeline hydrochloride hemihydrate
(CAS: 153504-70-2)

Cevimeline is a muscarinic M1 and M3 receptor agonist. Cevimeline stimulates secretion by the salivary glands and is used to treat the symptoms of dry mouth. Ce...

CAS 51-56-9 Homatropine Bromide

Homatropine Bromide
(CAS: 51-56-9)

Homatropine Bromide is an muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 1...

CAS 286930-03-8 Fesoterodine Fumarate

Fesoterodine Fumarate
(CAS: 286930-03-8)

Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor...

CAS 146422-58-4 CDD0102

CDD0102
(CAS: 146422-58-4)

CDD0102 is a selective M1 agonist which stimulated the secretion of APP from CHO-K1 cells expressing M1 receptors and penetrated into the brain following i.p. a...

Chemical Structure

CAS 76-90-4 Mepenzolate Bromide

Quick Inquiry

Verification code

Featured Items